Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Completed 3Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 40Gastrointestinal 3Other solid neoplasm 1Gynecologic 1

Conditions

Carcinoma, Hepatocellular 3

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × gallium 68 PSMA-11 × Gastrointestinal × Clear all
NCT05176223 2026-02-05

68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer

Mayo Clinic

Phase 2 Completed
29 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04762888 2025-10-31

68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer

Mayo Clinic

Phase 2 Completed
52 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04310540 2024-09-19

PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer

Mayo Clinic

Phase EARLY_PHASE1 Completed
42 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡